Assess your
current system

It's time for

Something different

Historically, to maintain therapy with certain systems, it was necessary to charge the device frequently (sometimes daily). Now, thanks to the power of BurstDR™ stimulation therapy on the Proclaim™ XR SCS system, you can get pain relief with very low amounts, or doses, of stimulation. This means you can have hassle-free pain relief with a battery that lasts up to 10 years at low-dose settings* without ever needing to charge the system.

If you have grown tired of recharging your system, experience discomfort while charging or have other challenges with your current system (such as loss of pain relief or feeling tingling sensations1), it may be time to talk to your doctor about the Proclaim XR recharge-free SCS system.

Why Proclaim XR

If you are currently using neurostimulation to manage your chronic pain, ask yourself:

Is charging interfering with your daily activities?

Is it taking you longer to charge your battery?

Are you getting “IPG low” messages more frequently?

Are you having issues maintaining your charger?

Eliminate recharging with the Proclaim XR recharge-free SCS system.

Don't let charging

Take charge of your life

The Proclaim XR SCS system provides recharge-free pain relief, unlike rechargeable systems that require frequent charging sessions to maintain therapy.

Ask your doctor for the Proclaim XR SCS system. The bold choice in chronic pain relief in a system that lasts up to 10 years at low-dose settings* without the hassle of recharging.

REFERENCES:

*Up to 10 years of battery longevity at the lowest dose setting: 0.6mA, 500 Ohms, duty cycle 30s on/360s off. NOTE: In neurostimulation therapy, ‘dose’ refers to the delivery of a quantity of energy to tissue. Safety comparisons and specific dose-response curves for each dosage have not been clinically established. Refer to the IFU for additional information. Hassle-free means recharge-free.

**Devices with one-hour recharge per day.

1. Hayek SM, Veizi E, Hanes M. (2015). Treatment-Limiting Complications of Percutaneous Spinal Cord Stimulator Implants: A Review of Eight Years of Experience From an Academic Center Database. Neuromodulation: Technology at the Neural Interface. (N=345)

Important Safety Information

SJM-PXR-0919-0035